Buy 5F-SDB005 Powder online

$30.00 – $3,300.00

We give just top-quality items to investigate purposes as it were. In our online store, you can locate the most characteristic and 100% unadulterated MCPEP. We deal with our purchasers and expect to give them administrations on an elevated level.

Buy 5F-SDB005 Powder is an indazole-based synthetic cannabinoid that has been sold online as a designer drug.

It is presumed to be an agonist of the CB1 and CB2 cannabinoid receptors. SDB-005 is the indazole core analog of

PB-22 where the 8-hydroxyquinoline has also been replaced with a naphthalene group.

The code number SDB-005 was originally used for a different compound, the N-phenyl instead of N-benzyl analogue

of SDB-006. This compound is a potent agonist of the CB1 receptor (Ki = 21 nM) and CB2 receptor (Ki = 140 nM).

However, SDB-005 was subsequently used as the name for the indazole-3-carboxylate compound mentioned above

when it was sold in Europe as a designer drug, and was entered into the EMCDDA synthetic drug database under this

name. Consequently, there are now two distinct, yet fairly closely related cannabinoid compounds, which may both be referred to under the code SDB-005.

Technical Information
Formal Name: naphthalen-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate
Molecular Formula: C23H21FN2O2
Formula Weight: 376.4
Purity: ?98%
Formulation: A crystalline solid
?max: 221, 302 nm
SMILES: O=C(OC1=C(C=CC=C2)C2=CC=C1)C3=NN(CCCCCF)C4=CC=CC=C43
InChi CodeInChI=1S/C23H21FN2O2/c24-15-6-1-7-16-26-20-13-5-4-12-19(20)22(25-26)23(27)28-21-14-8-10-17-9-2-3-11-18(17)21/h2-5,8-14H,1,6-7,15-16H2
InChi Key: FNMFGMMHNFDPNT-UHFFFAOYSA-N
Shipping & Storage Information
Storage: -20°C
Shipping: Room Temperature in continental US; may vary elsewhere
Stability: ? 2 years
WARNING This product is not for human or veterinary use.

SDB-005 is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. It is presumed to be an agonist of the CB₁ and CB₂ cannabinoid receptors. SDB-005 is the indazole core analog of PB-22 where the 8-hydroxyquinoline has also been replaced with a naphthalene group.

The code number SDB-005 was originally used for a different compound, the N-phenyl instead of N-benzyl analogue of SDB-006. This compound is a potent agonist of the CB₁ receptor (K_i = 21 nM) and CB₂ receptor (K_i = 140 nM).